Abiopharma

🔍 BIERE PETER (Executive)

Company: IZEA Worldwide, Inc. (IZEA)

Report Date: 2026-04-30

Detailed Transactions and Holdings:

• Acquired 79 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 92,868.00 | transaction_form_type: 4
• Acquired 200 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 93,068.00 | transaction_form_type: 4
• Acquired 2,284 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 95,352.00 | transaction_form_type: 4
• Acquired 2,455 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 97,807.00 | transaction_form_type: 4
• Acquired 1,775 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 99,582.00 | transaction_form_type: 4
• Acquired 2,145 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 101,727.00 | transaction_form_type: 4
• Acquired 1,737 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 103,464.00 | transaction_form_type: 4
• Acquired 1,973 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 105,437.00 | transaction_form_type: 4
• Acquired 9,533 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 114,970.00 | transaction_form_type: 4
• Sold 8,734 shares of Common Stock at $4.1 per share (Direct)
  Date: 2026-04-30 | Code: F | equity_swap_involved: 0 | shares_owned_after: 106,236.00 | transaction_form_type: 4
• Sold 79 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-30 | Code: M | Exercise: 2023-04-01 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 200 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-30 | Code: M | Exercise: 2024-04-01 | equity_swap_involved: 0 | shares_owned_after: 2,400.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 2,284 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-30 | Code: M | Exercise: 2024-10-31 | equity_swap_involved: 0 | shares_owned_after: 4,568.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 2,455 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-30 | Code: M | Exercise: 2025-01-31 | equity_swap_involved: 0 | shares_owned_after: 7,363.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 1,775 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-30 | Code: M | Exercise: 2025-04-30 | equity_swap_involved: 0 | shares_owned_after: 7,098.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 2,145 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-30 | Code: M | Exercise: 2025-07-31 | equity_swap_involved: 0 | shares_owned_after: 10,725.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 1,737 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-30 | Code: M | Exercise: 2025-10-31 | equity_swap_involved: 0 | shares_owned_after: 10,423.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 1,973 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-30 | Code: M | Exercise: 2026-01-31 | equity_swap_involved: 0 | shares_owned_after: 13,814.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 9,533 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-30 | Code: M | Exercise: 2026-04-30 | equity_swap_involved: 0 | shares_owned_after: 19,066.00 | transaction_form_type: 4 | Footnotes: F1, F10
• Acquired 14,439 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-30 | Code: A | Exercise: 2027-04-30 | equity_swap_involved: 0 | shares_owned_after: 14,439.00 | transaction_form_type: 4 | Footnotes: F1, F11

Footnotes:

• F1: Each Restricted Stock Unit represents a contingent right to receive at settlement one share of Issuer common stock.
• F2: These Restricted Stock Units were issued under the Issuer's 2011 Equity Incentive Plan on April 1, 2022 and vest 25% after one year and then 75% in 36 equal monthly installments commencing on the last day of each succeeding month thereafter.
• F3: These Restricted Stock Units were issued under the Issuer's 2011 Equity Incentive Plan on April 1, 2023 pursuant to the reporting person's employment agreement and vest 25% in one year and 75% in equal monthly installments over 36 months.
• F4: These Restricted Stock Units were issued under the Issuer's 2011 Equity Incentive Plan on October 31, 2023 pursuant to the reporting person's employment agreement and vest 25% in one year and 75% in equal quarterly installments over 24 months.
• F5: These Restricted Stock Units were issued under the Issuer's 2011 Equity Incentive Plan on January 31, 2024 pursuant to the reporting person's employment agreement and vest 25% in one year and 75% in equal quarterly installments over 24 months.
• F6: These Restricted Stock Units were issued under the Issuer's 2011 Equity Incentive Plan on April 30, 2024, and vest over a three-year term, one-third vesting 12 months from the grant date and then in equal quarterly installments after that.
• F7: These Restricted Stock Units were issued under the Issuer's 2011 Equity Incentive Plan on July 31, 2024, and vest over a three-year term, one-third vesting 12 months from the grant date and then in equal quarterly installments after that.
• F8: These Restricted Stock Units were issued under the Issuer's 2011 Equity Incentive Plan on October 31, 2024, and vest over a three-year term, one-third vesting 12 months from the grant date and then in equal quarterly installments after that.
• F9: These Restricted Stock Units were issued under the Issuer's 2011 Equity Incentive Plan on January 1, 2025 and with 1/3rd cliff vesting after one year and then quarterly over two years.
• F10: These Restricted Stock Units were issued under the Issuer's 2011 Equity Incentive Plan on April 30, 2025, and vest over a three-year term, one-third vesting 12 months from the grant date and then in equal quarterly installments after that.
• F11: These Restricted Stock Units were issued under the Issuer's 2011 Equity Incentive Plan on April 30, 2026, pursuant to the reporting person's employment agreement and vest 1/3 at one year then quarterly over 2 years.